vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.

Vital Farms, Inc. is the larger business by last-quarter revenue ($213.6M vs $142.0M, roughly 1.5× Oncology Institute, Inc.). Vital Farms, Inc. runs the higher net margin — 7.6% vs -5.3%, a 12.9% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 28.7%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-32.1M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 20.2%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".

TOI vs VITL — Head-to-Head

Bigger by revenue
VITL
VITL
1.5× larger
VITL
$213.6M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+12.9% gap
TOI
41.6%
28.7%
VITL
Higher net margin
VITL
VITL
12.9% more per $
VITL
7.6%
-5.3%
TOI
More free cash flow
TOI
TOI
$34.3M more FCF
TOI
$2.2M
$-32.1M
VITL
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
20.2%
VITL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TOI
TOI
VITL
VITL
Revenue
$142.0M
$213.6M
Net Profit
$-7.5M
$16.3M
Gross Margin
35.8%
Operating Margin
-4.9%
10.0%
Net Margin
-5.3%
7.6%
Revenue YoY
41.6%
28.7%
Net Profit YoY
43.0%
54.3%
EPS (diluted)
$-0.04
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
VITL
VITL
Q4 25
$142.0M
$213.6M
Q3 25
$136.6M
$198.9M
Q2 25
$119.8M
$184.8M
Q1 25
$104.4M
$162.2M
Q4 24
$100.3M
$166.0M
Q3 24
$99.9M
$145.0M
Q2 24
$98.6M
$147.4M
Q1 24
$94.7M
$147.9M
Net Profit
TOI
TOI
VITL
VITL
Q4 25
$-7.5M
$16.3M
Q3 25
$-16.5M
$16.4M
Q2 25
$-17.0M
$16.6M
Q1 25
$-19.6M
$16.9M
Q4 24
$-13.2M
$10.6M
Q3 24
$-16.1M
$7.4M
Q2 24
$-15.5M
$16.3M
Q1 24
$-19.9M
$19.0M
Gross Margin
TOI
TOI
VITL
VITL
Q4 25
35.8%
Q3 25
37.7%
Q2 25
38.9%
Q1 25
38.5%
Q4 24
36.1%
Q3 24
36.9%
Q2 24
39.1%
Q1 24
39.8%
Operating Margin
TOI
TOI
VITL
VITL
Q4 25
-4.9%
10.0%
Q3 25
-5.9%
10.8%
Q2 25
-9.4%
12.9%
Q1 25
-9.5%
13.4%
Q4 24
-11.9%
7.8%
Q3 24
-13.9%
6.4%
Q2 24
-16.6%
11.6%
Q1 24
-19.0%
16.3%
Net Margin
TOI
TOI
VITL
VITL
Q4 25
-5.3%
7.6%
Q3 25
-12.1%
8.3%
Q2 25
-14.2%
9.0%
Q1 25
-18.8%
10.4%
Q4 24
-13.1%
6.4%
Q3 24
-16.1%
5.1%
Q2 24
-15.7%
11.1%
Q1 24
-21.0%
12.9%
EPS (diluted)
TOI
TOI
VITL
VITL
Q4 25
$-0.04
$0.35
Q3 25
$-0.14
$0.36
Q2 25
$-0.15
$0.36
Q1 25
$-0.21
$0.37
Q4 24
$-0.14
$0.23
Q3 24
$-0.18
$0.16
Q2 24
$-0.17
$0.36
Q1 24
$-0.22
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
VITL
VITL
Cash + ST InvestmentsLiquidity on hand
$48.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
$351.3M
Total Assets
$164.7M
$518.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
VITL
VITL
Q4 25
$48.8M
Q3 25
$93.8M
Q2 25
$108.2M
Q1 25
$156.3M
Q4 24
$150.6M
Q3 24
$149.5M
Q2 24
$9.9M
$133.2M
Q1 24
$29.8M
$113.8M
Stockholders' Equity
TOI
TOI
VITL
VITL
Q4 25
$-15.7M
$351.3M
Q3 25
$-12.3M
$331.2M
Q2 25
$-9.0M
$309.8M
Q1 25
$5.1M
$288.9M
Q4 24
$3.6M
$269.3M
Q3 24
$15.5M
$253.4M
Q2 24
$29.2M
$238.4M
Q1 24
$41.3M
$213.3M
Total Assets
TOI
TOI
VITL
VITL
Q4 25
$164.7M
$518.7M
Q3 25
$163.6M
$481.5M
Q2 25
$159.8M
$430.8M
Q1 25
$164.0M
$376.9M
Q4 24
$172.7M
$359.3M
Q3 24
$179.2M
$344.7M
Q2 24
$179.6M
$320.5M
Q1 24
$204.5M
$300.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
VITL
VITL
Operating Cash FlowLast quarter
$3.2M
$5.8M
Free Cash FlowOCF − Capex
$2.2M
$-32.1M
FCF MarginFCF / Revenue
1.5%
-15.1%
Capex IntensityCapex / Revenue
0.7%
17.8%
Cash ConversionOCF / Net Profit
0.35×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$-48.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
VITL
VITL
Q4 25
$3.2M
$5.8M
Q3 25
$-12.6M
$23.4M
Q2 25
$-10.2M
$-761.0K
Q1 25
$-5.0M
$5.3M
Q4 24
$4.2M
$14.8M
Q3 24
$819.0K
$10.0M
Q2 24
$-15.7M
$16.1M
Q1 24
$-15.9M
$23.9M
Free Cash Flow
TOI
TOI
VITL
VITL
Q4 25
$2.2M
$-32.1M
Q3 25
$-13.2M
$-10.6M
Q2 25
$-11.4M
$-7.6M
Q1 25
$-5.3M
$2.1M
Q4 24
$2.4M
$-3.4M
Q3 24
$417.0K
$6.4M
Q2 24
$-17.5M
$10.5M
Q1 24
$-16.5M
$22.6M
FCF Margin
TOI
TOI
VITL
VITL
Q4 25
1.5%
-15.1%
Q3 25
-9.7%
-5.3%
Q2 25
-9.5%
-4.1%
Q1 25
-5.1%
1.3%
Q4 24
2.4%
-2.0%
Q3 24
0.4%
4.4%
Q2 24
-17.7%
7.2%
Q1 24
-17.4%
15.3%
Capex Intensity
TOI
TOI
VITL
VITL
Q4 25
0.7%
17.8%
Q3 25
0.4%
17.1%
Q2 25
1.0%
3.7%
Q1 25
0.3%
1.9%
Q4 24
1.8%
10.9%
Q3 24
0.4%
2.5%
Q2 24
1.9%
3.8%
Q1 24
0.6%
0.9%
Cash Conversion
TOI
TOI
VITL
VITL
Q4 25
0.35×
Q3 25
1.43×
Q2 25
-0.05×
Q1 25
0.31×
Q4 24
1.40×
Q3 24
1.34×
Q2 24
0.99×
Q1 24
1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

VITL
VITL

Eggs And Egg Related Products$205.8M96%
Butter And Butter Related Products$7.7M4%

Related Comparisons